Preclinical trial for prevention of metastasis of hepatocellular carcinoma by targeting c-Met –dependent and –independent signaling using LZ8
碩士 === 慈濟大學 === 醫學檢驗生物技術學系醫學生物技術碩士班 === 102 === Hepatocellular carcinoma (HCC) is one of the most common causes of death from cancer worldwide. Surgery of small HCC may result in marked increase in 5-year survival rate from 20% to 50%. However, the poor prognosis and recurrence of HCC are very high,...
Main Authors: | Pei-Ling Ma, 馬珮羚 |
---|---|
Other Authors: | Wen-Sheng Wu |
Format: | Others |
Language: | zh-TW |
Published: |
2014
|
Online Access: | http://ndltd.ncl.edu.tw/handle/r83j6d |
Similar Items
-
Preclinical trials for prevention of tumor progression of hepatocellular carcinoma by LZ-8 targeting c-Met dependent and independent pathways.
by: Jia-Ru Wu, et al.
Published: (2015-01-01) -
Epigenetic upregulation of HGF and c-Met drives metastasis in hepatocellular carcinoma.
by: Olorunseun O Ogunwobi, et al.
Published: (2013-01-01) -
Recombinant LZ-8-induced CD4+CD25+T Cells in Cytokines Expression and Immunomodulatory Function
by: Li-Juan Ma, et al.
Published: (2009) -
The LZ UK Data Centre
by: Bauer Daniela, et al.
Published: (2019-01-01) -
Preclinical Evaluation of Liposomal C8 Ceramide as a Potent anti-Hepatocellular Carcinoma Agent.
by: Huiqing Lv, et al.
Published: (2016-01-01)